Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMDEYLO)

Drug Name	V114 DMDEYLO
Synonyms	MK-V114; 15-valent im pneumococcal conjugate vaccine (pneumococcal disease), Merck & Co
Drug Type	Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pneumococcal infection	DIS6SXQD	CA00-CA40	Phase 3	[1]
------------------------------------------------------------------------------------

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04384107) Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01215188) A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003 AM2). U.S. National Institutes of Health.